Skip to main content
. 2023 Jun 7;10:1100006. doi: 10.3389/fcvm.2023.1100006

Table 16.

Proportion of the adverse events.

Adverse event Treatment group (n = 274) Control group (n = 264)
Abnormal blood routine [n (%)] 1 (0.0036) 4 (0.0152)
Abdominal distension [n (%)] 1 (0.0036) 4 (0.0152)
Diarrhea [n (%)] 4 (0.0146) 5 (0.0189)
Nausea, vomiting [n (%)] 2 (0.0073) 4 (0.0152)
Thirst [n (%)] 0 (0) 2 (0.0076)
Abnormal liver function [n (%)] 1 (0.0036) 3 (0.0114)
Erythra [n (%)] 2 (0.0073) 2 (0.0076)
Insomnia [n (%)] 1 (0.0036) 1 (0.0038)
Add up [n (%)] 8 (0.0292) 23 (0.0871)